scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
Rhea-AI Summary
scPharmaceuticals (NASDAQ: SCPH), a pharmaceutical company focused on cardiorenal healthcare innovations, has scheduled its Q1 2025 financial results announcement for May 14, 2025, after market close. The company will host a conference call and audio webcast at 4:30 p.m. ET on the same day to discuss the quarterly results and provide a business update. Interested participants can access the call through a direct registration link, while the webcast and its replay will be available on the company's website under the Investor Relations section.
Positive
- None.
Negative
- None.
Management to host conference call and webcast, after-market on May 14, 2025, at 4:30 p.m. ET
BURLINGTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, May 14, 2025, to discuss the financial results for the first quarter 2025 and provide a business update.
Registration and access for the conference call can be completed through this direct registration link.
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., (781) 301-6869
kmiranda@scpharma.com
Investors:
Matthew Beck
astr partners, (917) 415-1750
matthew.beck@astrpartners.com
FAQ
When will SCPH release its Q1 2025 earnings?
What time is scPharmaceuticals Q1 2025 earnings call?
How can I access SCPH's Q1 2025 earnings call?
Where can I find the replay of SCPH's Q1 2025 earnings webcast?
